GO:0033596 TSC1-TSC2 complex: Signaling Hub, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0033596 (TSC1-TSC2 complex) is a biological process term describing the heterodimeric tumor suppressor complex that integrates growth factor, energy, and stress signals to control cell growth.
• The TSC1-TSC2 complex acts as a GTPase-activating protein (GAP) for RHEB, thereby inhibiting mTORC1 signaling and downstream anabolic processes.
• Inactivating mutations in TSC1 or TSC2 cause tuberous sclerosis complex (TSC), a multisystem disorder characterized by hamartomas in brain, kidney, skin, and other organs [3,6].
• The complex is regulated by phosphorylation: Akt phosphorylates TSC2 and inhibits the complex, while AMPK activates it under energy stress.
• TSC1-TSC2 complex influences diverse processes including neuronal polarity, stem cell fate, and region-specific gene expression [1,4,8].
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) are essential for dissecting TSC1-TSC2 complex function and for validating patient-derived variants.
Description
The TSC1-TSC2 complex, annotated as GO:0033596, is a heterodimeric protein complex composed of TSC1 (hamartin) and TSC2 (tuberin) that serves as a central molecular switchboard controlling cell growth and proliferation. This complex integrates diverse upstream signals, including growth factors, energy status, and stress, to regulate the mechanistic target of rapamycin complex 1 (mTORC1) pathway. Dysregulation of the TSC1-TSC2 complex is directly linked to tuberous sclerosis complex (TSC), a genetic disorder affecting multiple organs, and to various cancers [3,6]. Understanding the biological processes governed by this complex is critical for researchers studying cell growth control, tumor suppression, and neurodevelopment [1,7]. The complex functions primarily as a GTPase-activating protein (GAP) for the small GTPase RHEB, converting RHEB to its inactive GDP-bound state and thereby suppressing mTORC1 activity. This regulation is essential for maintaining cellular homeostasis, and its disruption leads to uncontrolled growth and disease. Recent studies have highlighted additional roles for the TSC1-TSC2 complex in stem cell fate decisions and neuronal polarity, underscoring its broad biological significance [1,4].
TSC1-TSC2 complex At A Glance
| GO ID | GO:0033596 |
|---|---|
| GO term | TSC1-TSC2 complex |
| Ontology | biological_process |
| Synonym | None |
| Major function | Negative regulation of mTORC1 signaling via RHEB GAP activity; integration of growth and energy signals |
| Complex components | TSC1 (hamartin) and TSC2 (tuberin) |
| Upstream regulators | Akt (inhibitory phosphorylation of TSC2), AMPK (activating phosphorylation) |
| Downstream target | RHEB/mTORC1 pathway |
| Associated disease | Tuberous sclerosis complex (TSC), lymphangioleiomyomatosis, certain cancers [3,6] |
What Is GO:0033596?
The TSC1-TSC2 complex (GO:0033596) is a biological process term that encompasses the formation and function of a heterodimeric protein complex consisting of TSC1 and TSC2. This complex acts as a critical negative regulator of the mTORC1 signaling pathway, primarily through its GTPase-activating protein (GAP) activity toward RHEB. By integrating upstream signals such as growth factors, energy levels, and stress, the complex controls cell growth, proliferation, and survival. Mutations in either TSC1 or TSC2 disrupt this function, leading to constitutive mTORC1 activation and the development of tuberous sclerosis complex and certain cancers [3,6].
Why Is TSC1-TSC2 complex Important in Cell Biology?
The TSC1-TSC2 complex is a master regulator of cell growth and is central to understanding how cells respond to nutrient and growth factor signals. Its dysfunction is the molecular basis of tuberous sclerosis complex, a dominant genetic disorder with manifestations including epilepsy, autism, and benign tumors in multiple organs [3,6]. Moreover, the complex is implicated in cancer, as loss of TSC1 or TSC2 leads to hyperactive mTORC1, which drives tumorigenesis in various tissues. Studying this complex provides insights into fundamental signaling mechanisms and offers therapeutic targets for mTOR-related diseases [1,7].
• Mutations in TSC1 or TSC2 cause tuberous sclerosis complex (TSC), a multisystem disorder affecting brain, kidney, skin, and lungs [3,6].
• The complex is a key tumor suppressor, and its loss is associated with sporadic cancers such as renal cell carcinoma and lymphangioleiomyomatosis.
• It regulates neuronal polarity and development, linking mTORC1 signaling to neurodevelopmental disorders.
• The complex influences stem cell fate decisions, impacting tissue regeneration and homeostasis.
• It serves as a paradigm for understanding signal integration in growth control, with implications for metabolic diseases.
• TSC1-TSC2 complex activity is modulated by phosphorylation, making it a target for pharmacological intervention.
• Region-specific expression of TSC1 and TSC2 suggests tissue-specific roles in disease pathology.
• CRISPR-based models of TSC1/TSC2 mutations are crucial for functional assessment of patient variants.
What Happens During TSC1-TSC2 complex?
Complex Assembly and Stability
In simple terms: TSC1 and TSC2 proteins bind together to form a stable duo that acts as a brake on cell growth.
The TSC1-TSC2 complex is formed by the physical interaction between TSC1 (hamartin) and TSC2 (tuberin). TSC1 stabilizes TSC2 by preventing its ubiquitination and degradation, and the heterodimer is essential for the complex's function. This assembly is a prerequisite for the complex's ability to regulate downstream signaling. Disruption of this interaction, often due to mutations in either gene, leads to loss of function and disease.
Integration of Upstream Signals
In simple terms: The complex listens to signals from growth factors and energy sensors to decide whether to allow cell growth.
The TSC1-TSC2 complex receives inputs from multiple signaling pathways. Growth factors activate Akt, which phosphorylates TSC2 at multiple sites, inhibiting the complex and relieving its suppression of mTORC1. Conversely, energy stress activates AMPK, which phosphorylates TSC2 and enhances the complex's activity, leading to mTORC1 inhibition. This integration allows the complex to act as a molecular switchboard, coordinating cell growth with environmental conditions.
GAP Activity and mTORC1 Inhibition
In simple terms: The complex directly turns off a small switch called RHEB, which is needed to activate the growth-promoting mTORC1.
The TSC1-TSC2 complex functions as a GTPase-activating protein (GAP) for the small GTPase RHEB. By stimulating RHEB's intrinsic GTP hydrolysis, the complex converts RHEB from its active GTP-bound form to the inactive GDP-bound form. Since RHEB-GTP is required for mTORC1 activation, this GAP activity effectively suppresses mTORC1 signaling. This is the central mechanism by which the complex inhibits cell growth and proliferation.
Downstream Effects on Cell Growth and Metabolism
In simple terms: By inhibiting mTORC1, the complex reduces protein synthesis and other growth processes.
Inhibition of mTORC1 by the TSC1-TSC2 complex leads to decreased phosphorylation of downstream effectors such as S6K1 and 4E-BP1, resulting in reduced protein synthesis, cell cycle progression, and anabolic metabolism. This regulation is critical for maintaining cellular homeostasis and preventing uncontrolled growth. Loss of the complex results in constitutive mTORC1 activation, driving abnormal proliferation and tumorigenesis.
Role in Neuronal Polarity and Stem Cell Fate
In simple terms: The complex also helps nerve cells develop properly and influences how stem cells decide what to become.
Beyond growth control, the TSC1-TSC2 complex influences neuronal polarity by modulating TORC1 activity and SAD kinase levels. In stem cells, the complex regulates fate decisions, affecting differentiation and self-renewal. These additional roles highlight the complex's importance in development and tissue homeostasis, and their disruption may contribute to neurological and developmental symptoms in TSC [1,4].
Key Genes Involved in GO:0033596 TSC1-TSC2 complex
The following genes and proteins are key components or regulators of the TSC1-TSC2 complex and its signaling network.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TSC1 | Encodes hamartin, stabilizes TSC2 and forms the core complex | Mutations cause TSC; knockout models show mTORC1 hyperactivation [3,6] |
| TSC2 | Encodes tuberin, contains GAP domain for RHEB | Mutations cause TSC; point mutations used to assess patient variants [3,6] |
| RHEB | Small GTPase directly inhibited by TSC2 GAP activity | Key downstream effector; knockout/knock-in models to study mTORC1 |
| MTOR | Kinase subunit of mTORC1, activated by RHEB-GTP | Central to growth signaling; target of rapamycin inhibitors |
| AKT1 | Phosphorylates TSC2 and inhibits the complex | Upstream regulator; overexpression models to study feedback |
| PRKAA1 | AMPK catalytic subunit, phosphorylates TSC2 under energy stress | Energy sensor; knockout models to study metabolic regulation |
| RPTOR | Component of mTORC1, mediates substrate recruitment | mTORC1 scaffold; knockout affects downstream signaling |
| RPS6KB1 | S6K1, downstream effector of mTORC1 | Phosphorylation readout for mTORC1 activity |
| EIF4EBP1 | 4E-BP1, downstream effector of mTORC1 | Phosphorylation readout for mTORC1 activity |
| SAD-A/B | Kinases involved in neuronal polarity, modulated by TSC complex | Neuronal polarity studies; knockout affects axon formation |
| TBC1D7 | Third subunit of the TSC complex, stabilizes TSC1-TSC2 | Mutations cause TSC-like phenotypes; knockout models |
| DEPDC5 | Component of GATOR1, upstream regulator of mTORC1 | Mutations in epilepsy; knockout models |
| NPRL2 | Component of GATOR1, regulates mTORC1 in response to amino acids | Knockout affects mTORC1 signaling |
| LAMTOR1 | Component of Ragulator, recruits mTORC1 to lysosomes | Knockout disrupts mTORC1 activation |
| RRAGA | Rag GTPase, mediates amino acid signaling to mTORC1 | Knockout/knock-in to study nutrient sensing |
| PTEN | Lipid phosphatase, upstream regulator of Akt-TSC-mTORC1 axis | Tumor suppressor; knockout models for cancer research |
| STK11 | LKB1, activates AMPK upstream of TSC complex | Knockout models for metabolic and cancer studies |
| PIK3CA | Catalytic subunit of PI3K, activates Akt | Oncogene; overexpression models for cancer |
How Is TSC1-TSC2 complex Regulated?
The TSC1-TSC2 complex is regulated by multiple post-translational modifications and interacting proteins. Phosphorylation by Akt at TSC2 residues such as Ser939 and Thr1462 inhibits the complex, relieving mTORC1 suppression. In contrast, AMPK phosphorylates TSC2 at Ser1387 and Thr1271, enhancing complex activity under low energy conditions. Additionally, the complex is stabilized by TBC1D7, which binds to TSC1 and prevents degradation. Other regulators include ERK and RSK, which phosphorylate TSC2 and inhibit the complex in response to growth factors. This multilayered regulation ensures that mTORC1 activity is tightly coupled to cellular and environmental cues.
TSC1-TSC2 complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TSC1 | Tuberous sclerosis complex; hamartomas in brain, kidney, skin | TSC1 knockout iPSCs or mouse models; point mutations for variant assessment |
| TSC2 | Tuberous sclerosis complex; severe early-onset phenotypes | TSC2 knockout cell lines; knock-in of patient mutations |
| TSC1/TSC2 | Lymphangioleiomyomatosis (LAM) | TSC2-null cell lines; xenograft models |
| TSC1/TSC2 | Renal cell carcinoma | Knockout in renal epithelial cells; overexpression of mutant TSC2 |
| TSC1/TSC2 | Neurodevelopmental disorders (autism, epilepsy) | Neuronal differentiation from patient iPSCs; Tsc1/Tsc2 knockout mice [4,7] |
Tuberous Sclerosis Complex (TSC)
TSC is an autosomal dominant disorder caused by inactivating mutations in TSC1 or TSC2, leading to constitutive mTORC1 activation [3,6]. Clinical manifestations include cortical tubers, subependymal giant cell astrocytomas, renal angiomyolipomas, skin lesions, and epilepsy. Mutation landscape studies in Chinese patients have identified a wide spectrum of TSC1/TSC2 variants, many of which are missense mutations requiring functional assessment. The TSC1-TSC2 complex is therefore central to TSC pathogenesis, and restoring its function is a therapeutic goal.
Cancer and Lymphangioleiomyomatosis
Loss of TSC1 or TSC2 function is associated with sporadic cancers, including renal cell carcinoma and lymphangioleiomyomatosis (LAM), a progressive lung disease. In these settings, hyperactive mTORC1 drives cell proliferation and survival. The TSC1-TSC2 complex acts as a tumor suppressor, and its inactivation is a key event in tumorigenesis. Targeting mTORC1 with rapamycin analogs has shown clinical benefit in LAM and some TSC-associated tumors.
Neurological and Neurodevelopmental Disorders
The TSC1-TSC2 complex is highly expressed in the brain and regulates neuronal polarity and development [4,7]. Disruption of the complex leads to neurodevelopmental abnormalities, including autism spectrum disorder and intellectual disability in TSC patients. Studies in Drosophila and mouse models have shown that Tsc1-Tsc2 influences axon guidance and synapse formation through TORC1 and SAD kinases. Region-specific expression of TSC1 and TSC2 may underlie the variable neurological phenotypes observed in TSC.
From TSC1-TSC2 complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the effect of TSC1/TSC2 loss on mTORC1 signaling? | TSC1 or TSC2 knockout cell lines (e.g., HEK293T, MEFs) |
| How do patient-derived TSC2 missense variants affect complex function? | Point mutation knock-in via CRISPR in isogenic cell lines |
| Does restoration of TSC2 rescue mTORC1 hyperactivation? | Knock-in of wild-type TSC2 or overexpression |
| How does TSC1-TSC2 complex regulate neuronal polarity? | Tsc1/Tsc2 knockout in primary neurons or Drosophila |
| What is the role of TSC1-TSC2 in stem cell fate? | TSC1/TSC2 knockout or overexpression in iPSCs, followed by differentiation |
| How does energy stress modulate TSC complex activity? | AMPK knockout or point mutations in TSC2 phosphorylation sites |
How to Study the TSC1-TSC2 complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout | Loss of TSC1 or TSC2 protein | Studying mTORC1 hyperactivation and downstream effects |
| CRISPR point mutation knock-in | Effect of specific patient variants | Functional assessment of TSC1/TSC2 mutations |
| Western blot | Phosphorylation of S6K1 and 4E-BP1 | Readout of mTORC1 activity |
| Co-immunoprecipitation | Interaction between TSC1 and TSC2 | Complex assembly and stability |
| GAP assay | RHEB GTP hydrolysis | Direct measurement of TSC2 GAP activity |
| RNA-seq | Transcriptional changes | Identifying downstream pathways and biomarkers |
| Phosphoproteomics | Global phosphorylation changes | Mapping signaling networks and TSC2 substrates |
| Fluorescence microscopy | Subcellular localization of complex | Studying lysosomal recruitment and dynamics |
CRISPR-Cas9 Genome Editing
CRISPR-Cas9 is widely used to generate knockout, point mutation, and knock-in models of TSC1 and TSC2. Knockout cell lines are created by introducing indels in early exons, leading to loss of protein expression. Point mutations identified in TSC patients can be precisely introduced to assess their functional impact on complex stability and mTORC1 signaling. Knock-in of tagged TSC1 or TSC2 allows for localization and interaction studies. These models are essential for validating variant pathogenicity and dissecting molecular mechanisms.
Biochemical Assays for mTORC1 Activity
Western blotting for phosphorylated S6K1 (Thr389) and 4E-BP1 (Ser65) is commonly used to measure mTORC1 activity downstream of the TSC1-TSC2 complex. Immunoprecipitation can assess the interaction between TSC1 and TSC2, and in vitro GAP assays measure RHEB GTP hydrolysis. These methods are critical for determining how mutations or treatments affect complex function.
Transcriptomics and Proteomics
RNA sequencing (RNA-seq) can reveal global transcriptional changes upon TSC1/TSC2 loss or restoration, providing insights into downstream pathways. Proteomic approaches, such as mass spectrometry, can identify phosphorylation sites on TSC2 and interacting proteins. These high-throughput methods help map the signaling network controlled by the complex.
Imaging and Localization Studies
Fluorescence microscopy of tagged TSC1 or TSC2 can determine subcellular localization, which is important for understanding complex function at lysosomes and other compartments. Live-cell imaging can track mTORC1 activity using fluorescent reporters. These techniques complement biochemical assays and provide spatial context.
How CRISPR Can Be Used to Study GO:0033596 TSC1-TSC2 complex
Knockout
CRISPR knockout of TSC1 or TSC2 is a powerful approach to abolish complex function and study the consequences of mTORC1 hyperactivation. Knockout cell lines, such as TSC2-/- MEFs or HEK293T cells, exhibit constitutive S6K1 phosphorylation and altered growth properties. These models are used to test mTOR inhibitors and to identify synthetic lethal interactions. Knockout of TSC1 or TSC2 in iPSCs followed by differentiation can model tissue-specific effects, such as neuronal abnormalities.
Point Mutation
Many TSC1/TSC2 mutations are missense variants whose pathogenicity is unclear. CRISPR-mediated point mutation knock-in allows the introduction of specific patient variants into the endogenous locus, preserving physiological expression levels. These isogenic models are ideal for functional assessment, such as measuring TSC2 stability, GAP activity, and mTORC1 suppression. Such studies have classified variants as pathogenic or benign, aiding genetic counseling.
Knock-in
Knock-in of tagged TSC1 or TSC2 (e.g., GFP or HA) enables visualization and purification of the complex. This approach can also be used to introduce wild-type or mutant TSC2 into TSC2-null cells to rescue or assess function. Knock-in of luciferase reporters downstream of mTORC1 targets can provide sensitive readouts for drug screening. These models are valuable for studying complex dynamics and localization.
Overexpression
Overexpression of TSC1 and TSC2, often from plasmid or lentiviral vectors, is used to enhance complex activity and suppress mTORC1. This can rescue phenotypes in TSC-deficient cells and is useful for structure-function studies. However, overexpression may cause artifacts, so careful controls are needed. Inducible overexpression systems allow temporal control of complex levels.
How EDITGENE Supports TSC1-TSC2 complex Research
Researchers studying TSC1-TSC2 complex-related genes often need to determine whether a candidate gene is causally involved in complex regulation, mTORC1 signaling, or disease pathogenesis. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models, enabling functional validation and mechanistic studies.
Contact EDITGENE today to design your custom CRISPR model for TSC1-TSC2 complex research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| TBC1D7 Knockout HEK293 Cell Line | EDJ-KQ1183 | Human | 51256 | Details Get a Quote |
| TSC1 Knockout HEK293 Cell Line | EDJ-KQ17911 | Human | 7248 | Details Get a Quote |
| TSC2 Knockout HEK293 Cell Line | EDJ-KQ17912 | Human | 7249 | Details Get a Quote |
| TSC2 Knockout HCT 116 Cell Line | EDJ-KQ18154 | Human | 7249 | Details Get a Quote |
| TSC1 Knockout HCT 116 Cell Line | EDJ-KQ18155 | Human | 7248 | Details Get a Quote |
| TSC1 Knockout A-549 Cell Line | EDJ-KQ19693 | Human | 7248 | Details Get a Quote |
| TSC1 Knockout HeLa Cell Line | EDJ-KQ19694 | Human | 7248 | Details Get a Quote |
| TSC2 Knockout A-549 Cell Line | EDJ-KQ19695 | Human | 7249 | Details Get a Quote |
| TSC2 Knockout HeLa Cell Line | EDJ-KQ19696 | Human | 7249 | Details Get a Quote |
| TBC1D7 Knockout A-549 Cell Line | EDJ-KQ20462 | Human | 51256 | Details Get a Quote |
| TBC1D7 Knockout HCT 116 Cell Line | EDJ-KQ20463 | Human | 51256 | Details Get a Quote |
| TBC1D7 Knockout HeLa Cell Line | EDJ-KQ20464 | Human | 51256 | Details Get a Quote |
| Tsc1 Knockout MC3T3-E1 Cell Line | EDJ-KZ65 | Mouse | 64930 | Details Get a Quote |
| Tsc2 Knockout NIH 3T3 Cell Line | EDJ-KZ66 | Mouse | 22084 | Details Get a Quote |
| Tsc2 Knockout RAW 264.7 Cell Line | EDJ-KZ67 | Mouse | 22084 | Details Get a Quote |
Frequently Asked Questions About TSC1-TSC2 complex
What is the TSC1-TSC2 complex?
The TSC1-TSC2 complex is a heterodimeric protein complex of TSC1 (hamartin) and TSC2 (tuberin) that inhibits mTORC1 signaling by acting as a GAP for RHEB.
What genes are involved in the TSC1-TSC2 complex?
The core genes are TSC1 and TSC2, which encode hamartin and tuberin, respectively. Other key genes include RHEB, MTOR, AKT1, and PRKAA1 [2,5].
What is the function of GO:0033596?
GO:0033596 describes the biological process of the TSC1-TSC2 complex, which integrates growth and energy signals to negatively regulate mTORC1 and control cell growth.
How is the TSC1-TSC2 complex regulated?
It is regulated by phosphorylation: Akt inhibits the complex, while AMPK activates it. TBC1D7 stabilizes the complex [2,5].
What diseases are associated with TSC1-TSC2 complex mutations?
Mutations cause tuberous sclerosis complex (TSC), lymphangioleiomyomatosis, and certain cancers due to hyperactive mTORC1 [3,6].
How can I study the TSC1-TSC2 complex using CRISPR?
CRISPR can generate knockout, point mutation, knock-in, and overexpression models in cell lines or iPSCs to assess complex function and variant pathogenicity.
What are the downstream effects of TSC1-TSC2 complex inhibition?
Inhibition leads to mTORC1 activation, increased protein synthesis, cell growth, and proliferation.
What is the role of TSC1-TSC2 complex in neurons?
It regulates neuronal polarity and development by modulating TORC1 activity and SAD kinases.
How does the TSC1-TSC2 complex affect stem cells?
It influences stem cell fate decisions, affecting differentiation and self-renewal.
What experimental models are available for TSC1-TSC2 research?
Common models include TSC1/TSC2 knockout cell lines, patient-derived iPSCs, and mouse models. EDITGENE provides custom CRISPR models.
Conclusion
The TSC1-TSC2 complex (GO:0033596) is a central regulator of cell growth and metabolism, with critical roles in development and disease. Its dysfunction underlies tuberous sclerosis complex and contributes to cancer and neurological disorders. Continued research using advanced CRISPR models will further elucidate its mechanisms and aid in developing targeted therapies. EDITGENE offers comprehensive services to support these investigations, from knockout and point mutation models to library screening and bioinformatics.
References
- 1. Wang S et al.. 2025. Unraveling the function of TSC1-TSC2 complex: implications for stem cell fate.. Stem Cell Res Ther 16(1):38 PMID: 39901197
- 2. Huang J et al.. 2008. The TSC1-TSC2 complex: a molecular switchboard controlling cell growth.. Biochem J 412(2):179-90 PMID: 18466115
- 3. Hoogeveen-Westerveld M et al.. 2013. Functional assessment of TSC2 variants identified in individuals with tuberous sclerosis complex.. Hum Mutat 34(1):167-75 PMID: 22903760
- 4. Wildonger J et al.. 2008. The Tsc1-Tsc2 complex influences neuronal polarity by modulating TORC1 activity and SAD levels.. Genes Dev 22(18):2447-53 PMID: 18794342
- 5. Inoki K et al.. 2002. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling.. Nat Cell Biol 4(9):648-57 PMID: 12172553
- 6. Meng Y et al.. 2021. Mutation landscape of TSC1/TSC2 in Chinese patients with tuberous sclerosis complex.. J Hum Genet 66(3):227-236 PMID: 32917966
- 7. Han JM et al.. 2011. TSC1/TSC2 signaling in the CNS.. FEBS Lett 585(7):973-80 PMID: 21329690
- 8. Li Y et al.. 2018. Regionally specific TSC1 and TSC2 gene expression in tuberous sclerosis complex.. Sci Rep 8(1):13373 PMID: 30190613
